{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:07:58Z","timestamp":1768435678458,"version":"3.49.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s00115-023-01600-6","type":"journal-article","created":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T15:02:22Z","timestamp":1704726142000},"page":"35-40","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Sicheres Absetzen von Psychopharmaka bei \u00e4lteren Menschen?","Safe discontinuation of psychotropic drugs in older people?"],"prefix":"10.1007","volume":"95","author":[{"given":"Daniel","family":"Kopf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,8]]},"reference":[{"issue":"1","key":"1600_CR1","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s11096-019-00784-9","volume":"41","author":"N Ailabouni","year":"2019","unstructured":"Ailabouni\u00a0N, Mangin\u00a0D, Nishtala\u00a0PS (2019) DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilities. Int J Clin Pharm 41(1):167\u2013178","journal-title":"Int J Clin Pharm"},{"issue":"1","key":"1600_CR2","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s40360-017-0183-0","volume":"18","author":"I Arnold","year":"2017","unstructured":"Arnold\u00a0I, Straube\u00a0K, Himmel\u00a0W et\u00a0al (2017) High prevalence of prescription of psychotropic drugs for older patients in a\u00a0general hospital. BMC Pharmacol Toxicol 18(1):76","journal-title":"BMC Pharmacol Toxicol"},{"key":"1600_CR3","doi-asserted-by":"publisher","first-page":"e1566","DOI":"10.1136\/bmj.e1566","volume":"344","author":"S Bergh","year":"2012","unstructured":"Bergh\u00a0S, Selb\u00e6k\u00a0G, Engedal\u00a0K (2012) Discontinuation of antidepressants in people with dementia and neuropsychiatric symptoms (DESEP study): double blind, randomised, parallel group, placebo controlled trial. BMJ 344:e1566","journal-title":"BMJ"},{"issue":"7","key":"1600_CR4","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.jamda.2018.05.002","volume":"19","author":"H Brodaty","year":"2018","unstructured":"Brodaty\u00a0H, Aerts\u00a0L, Harrison\u00a0F et al (2018) Antipsychotic deprescription for older adults in long-term care: the HALT study. J\u00a0Am Med Dir Assoc 19(7):592\u2013600.e7","journal-title":"J Am Med Dir Assoc"},{"key":"1600_CR5","doi-asserted-by":"publisher","unstructured":"Bundes\u00e4rztekammer (B\u00c4K), Kassen\u00e4rztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF). Nationale VersorgungsLeitlinie Unipolare Depression \u2013 Langfassung, Version 3.0. 2022 [cited: 2022-12-31]. https:\/\/doi.org\/10.6101\/AZQ\/000493. www.leitlinien.de\/depression","DOI":"10.6101\/AZQ\/000493"},{"key":"1600_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007726.pub2","author":"T Declercq","year":"2013","unstructured":"Declercq\u00a0T, Petrovic\u00a0M, Azermai\u00a0M et\u00a0al (2013) Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD007726.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"1600_CR7","unstructured":"DGBS e.\u202fV. und DGPPN e.\u202fV.: S3-Leitlinie zur Diagnostik und Therapie Bipolarer St\u00f6rungen. Langversion, 2019. Verf\u00fcgbar unter https:\/\/register.awmf.org\/assets\/guidelines\/038-019l_S3_Bipolare-Stoerungen-Diagnostik-Therapie_2020-05.pdf"},{"key":"1600_CR8","unstructured":"DGPPN e.\u202fV. (Hrsg.) f\u00fcr die Leitliniengruppe: S3-Leitlinie Schizophrenie. Langfassung, 2019, Version 1.0, zuletzt ge\u00e4ndert am 15. M\u00e4rz 2019, verf\u00fcgbar unter: https:\/\/www.awmf.org\/leitlinien\/detail\/ll\/038-009.html"},{"issue":"2","key":"1600_CR9","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1093\/fampra\/cmab143","volume":"39","author":"M Fernandes","year":"2022","unstructured":"Fernandes\u00a0M, Neves\u00a0I, Oliveira\u00a0J et\u00a0al (2022) Discontinuation of chronic benzodiazepine use in primary care: a\u00a0nonrandomized intervention. Fam Pract 39(2):241\u2013248","journal-title":"Fam Pract"},{"issue":"1","key":"1600_CR10","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12916-022-02382-5","volume":"20","author":"MH Gedde","year":"2022","unstructured":"Gedde\u00a0MH, Husebo\u00a0BS, Mannseth\u00a0J et al (2022) The impact of medication reviews by general practitioners on psychotropic drug use and behavioral and psychological symptoms in home-dwelling people with dementia: results from the multicomponent cluster randomized controlled LIVE@Home.Path trial. BMC Med 20(1):186","journal-title":"BMC Med"},{"issue":"3","key":"1600_CR11","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.jagp.2020.07.004","volume":"29","author":"MH Gedde","year":"2021","unstructured":"Gedde\u00a0MH, Husebo\u00a0BS, Mannseth\u00a0J et al (2021) Less is more: the impact of deprescribing psychotropic drugs on behavioral and psychological symptoms and daily functioning in nursing home patients. Results from the cluster-randomized controlled COSMOS trial. Am J Geriatr Psychiatry 29(3):304\u2013315","journal-title":"Am J Geriatr Psychiatry"},{"issue":"8","key":"1600_CR12","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s00391-021-01992-7","volume":"54","author":"V Holthoff-Detto","year":"2021","unstructured":"Holthoff-Detto\u00a0V, Seifert\u00a0K (2021) Stellenwert der psychotherapeutisch mitgepr\u00e4gten Behandlungsverfahren in der Gerontopsychiatrie und -psychotherapie. Z\u00a0Gerontol Geriatr 54(8):747\u2013752","journal-title":"Z Gerontol Geriatr"},{"issue":"4","key":"1600_CR13","first-page":"416","volume":"11","author":"LD Hughes","year":"2022","unstructured":"Hughes\u00a0LD (2022) Exploring the relationship between falls in long term care and psychoactive prescribing. J\u00a0Frailty Aging 11(4):416\u2013419","journal-title":"J Frailty Aging"},{"issue":"3","key":"1600_CR14","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1111\/bcp.14557","volume":"87","author":"L Kouladjian O\u2019Donnell","year":"2021","unstructured":"Kouladjian O\u2019Donnell\u00a0L, Gnjidic\u00a0D, Sawan\u00a0M et al (2021) Impact of the goal-directed medication review electronic decision support system on drug burden index: a cluster-randomised clinical trial in primary care. Br J Clin Pharmacol 87(3):1499\u20131511","journal-title":"Br J Clin Pharmacol"},{"key":"1600_CR15","doi-asserted-by":"publisher","first-page":"18","DOI":"10.7812\/TPP\/18-161","volume":"23","author":"JL Kuntz","year":"2019","unstructured":"Kuntz\u00a0JL, Kouch\u00a0L, Christian\u00a0D et\u00a0al (2019) Patient education and pharmacist consultation influence on nonbenzodiazepine sedative medication deprescribing success for older adults. Perm\u00a0J 23:18\u2013161","journal-title":"Perm J"},{"issue":"18","key":"1600_CR16","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1001\/jama.2018.16131","volume":"320","author":"P Martin","year":"2018","unstructured":"Martin\u00a0P, Tamblyn\u00a0R, Benedetti\u00a0A et al (2018) Effect of a\u00a0pharmacist-led educational intervention on inappropriate medication prescriptions in older adults: the D\u2011PRESCRIBE randomized clinical trial. JAMA 320(18):1889\u20131898","journal-title":"JAMA"},{"issue":"1","key":"1600_CR17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12877-017-0432-5","volume":"17","author":"P Martin","year":"2017","unstructured":"Martin\u00a0P, Tannenbaum\u00a0C (2017) Use of the EMPOWER brochure to deprescribe sedative-hypnotic drugs in older adults with mild cognitive impairment. BMC Geriatr 17(1):37. https:\/\/doi.org\/10.1186\/s12877-017-0432-5","journal-title":"BMC Geriatr"},{"issue":"11","key":"1600_CR18","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s40266-022-00980-9","volume":"39","author":"F Pazan","year":"2022","unstructured":"Pazan\u00a0F, Petrovic\u00a0M, Cherubini\u00a0A et\u00a0al (2022) A systematic review of the current evidence from randomised controlled trials on the impact of medication optimisation or pharmacological interventions on quantitative measures of cognitive function in geriatric patients. Drugs Aging 39(11):863\u2013874","journal-title":"Drugs Aging"},{"issue":"3","key":"1600_CR19","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1093\/ageing\/afz016","volume":"48","author":"C Richter","year":"2019","unstructured":"Richter\u00a0C, Berg\u00a0A, Langner\u00a0H et al (2019) Effect of person-centred care on antipsychotic drug use in nursing homes (EPCentCare): a\u00a0cluster-randomised controlled trial. Age Ageing 48(3):419\u2013425","journal-title":"Age Ageing"},{"key":"1600_CR20","first-page":"875","volume":"118","author":"H Rudolf","year":"2021","unstructured":"Rudolf\u00a0H, Thiem\u00a0U, Aust\u00a0K et\u00a0al (2021) Reduction of potentially inappropriate medication in the elderly. Dtsch Arztebl Int 118:875\u2013882","journal-title":"Dtsch Arztebl Int"},{"key":"1600_CR21","doi-asserted-by":"publisher","first-page":"e019042","DOI":"10.1136\/bmjopen-2017-019042","volume":"8","author":"HG van der Meer","year":"2018","unstructured":"van der Meer\u00a0HG, Wouters\u00a0H, Pont\u00a0LG, Taxis\u00a0K (2018) Reducing the anticholinergic and sedative load in older patients on polypharmacy by pharmacist-led medication review: a\u00a0randomised controlled trial. BMJ Open 8:e19042","journal-title":"BMJ Open"},{"key":"1600_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007726.pub3","author":"E van Leeuwen","year":"2018","unstructured":"van Leeuwen\u00a0E, Petrovic\u00a0M, van Driel\u00a0ML et al (2018) Withdrawal versus continuation of long-term antipsychotic drug use for behavioural and psychological symptoms in older people with dementia. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD007726.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"1600_CR23","doi-asserted-by":"publisher","first-page":"398","DOI":"10.5694\/mja17.00857","volume":"208","author":"JL Westbury","year":"2018","unstructured":"Westbury\u00a0JL, Gee\u00a0P, Ling\u00a0T et\u00a0al (2018) RedUSe: reducing antipsychotic and benzodiazepine prescribing in residential aged care facilities. Med J Aust 208:398\u2013403","journal-title":"Med J Aust"},{"issue":"2","key":"1600_CR24","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s00391-016-1171-5","volume":"50","author":"DK Wolter","year":"2017","unstructured":"Wolter\u00a0DK (2017) Benzodiazepine absetzen im Alter: Wann und, wenn ja, wie? Z\u00a0Gerontol Geriatr 50(2):115\u2013122","journal-title":"Z Gerontol Geriatr"},{"issue":"1","key":"1600_CR25","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s00391-021-01949-w","volume":"55","author":"C Wunner","year":"2022","unstructured":"Wunner\u00a0C, Stemmler\u00a0M, Masuch\u00a0J et\u00a0al (2022) Screening for depression in old age: a comparison of the geriatric depression scale and the depression in old age scale. Z\u00a0Gerontol Geriatr 55(1):44\u201345","journal-title":"Z Gerontol Geriatr"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-023-01600-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00115-023-01600-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-023-01600-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T10:04:20Z","timestamp":1706090660000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00115-023-01600-6"}},"subtitle":["Neue Evidenz und praktisches Vorgehen","New evidence and practical approach"],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["1600"],"URL":"https:\/\/doi.org\/10.1007\/s00115-023-01600-6","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"31 January 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"D.\u00a0Kopf gibt an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden vom Autor keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}